Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
43,675,086
-
Total 13F shares
-
3,723,388
-
Share change
-
+3,719,933
-
Total reported value
-
$65,402,629
-
Price per share
-
$17.56
-
Number of holders
-
14
-
Value change
-
+$65,341,948
-
Number of buys
-
13
Institutional Holders of MapLight Therapeutics, Inc. - Common Stock, $0.0001 par value per share (MPLT) as of Q4 2025
As of 31 Dec 2025,
MapLight Therapeutics, Inc. - Common Stock, $0.0001 par value per share (MPLT) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,723,388 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Blue Owl Capital Holdings LP, SEVEN GRAND MANAGERS, LLC, TD Asset Management Inc, Bank of New York Mellon Corp, UBS Group AG, BNP PARIBAS FINANCIAL MARKETS, and STRS OHIO.
This page lists
14
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.